Funded by a $1 million grant, the course aims to prepare social workers and nurses for the emerging field of psychedelic-assisted therapy, which is on the cusp of FDA approval. The curriculum, designed to be comprehensive and adaptable, will initially be piloted at Penn Nursing and Columbia’s School of Social Work, with plans for broader dissemination. The course not only equips healthcare professionals with the skills and knowledge to administer this innovative form of treatment but also addresses the larger goal of improving access to safe and affordable mental health care.
The course is particularly timely given the current mental health crisis and the fast-track status granted to psychedelic therapies for various conditions, including depression, anxiety, and PTSD. It offers associated practicums in psychedelic research, ketamine clinics, and other clinical settings, ensuring participants receive hands-on experience. By focusing on best practices and leveraging social workers’ and nurses’ complementary skill sets, the course aims to meet the anticipated demand for trained practitioners in this field, thereby minimizing bottlenecks and ensuring a diverse, highly qualified workforce.